Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to -$4.7 million.

  • Jaguar Health's Cash from Operations rose 2605.27% to -$4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.0 million, marking a year-over-year increase of 1028.99%. This contributed to the annual value of -$29.4 million for FY2024, which is 1160.58% up from last year.
  • As of Q3 2025, Jaguar Health's Cash from Operations stood at -$4.7 million, which was up 2605.27% from -$6.2 million recorded in Q2 2025.
  • Jaguar Health's 5-year Cash from Operations high stood at -$4.7 million for Q3 2025, and its period low was -$10.5 million during Q2 2022.
  • Its 5-year average for Cash from Operations is -$7.8 million, with a median of -$7.7 million in 2022.
  • Its Cash from Operations has fluctuated over the past 5 years, first plummeted by 22312.44% in 2021, then surged by 2914.03% in 2024.
  • Quarter analysis of 5 years shows Jaguar Health's Cash from Operations stood at -$8.9 million in 2021, then increased by 28.02% to -$6.4 million in 2022, then decreased by 16.0% to -$7.5 million in 2023, then dropped by 5.03% to -$7.8 million in 2024, then soared by 40.08% to -$4.7 million in 2025.
  • Its Cash from Operations was -$4.7 million in Q3 2025, compared to -$6.2 million in Q2 2025 and -$7.3 million in Q1 2025.